Drug Profile
Research programme: pain therapeutics - Aerial BioPharma
Alternative Names: Prostatic acid phosphatase - Aerial BioPharmaLatest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Aerial BioPharma
- Class Enzymes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for preclinical development in Pain in USA (Parenteral)
- 23 Jan 2014 Preclinical trials in Pain in USA (Parenteral)